People's United Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-7,845
Closed -$261K 883
2017
Q2
$261K Sell
7,845
-256
-3% -$7.92K 0.01% 574
2017
Q1
$260K Sell
8,101
-1,988
-20% -$67.8K 0.01% 567
2016
Q4
$365K Sell
10,089
-10,219
-50% -$408K 0.01% 499
2016
Q3
$935K Buy
20,308
+377
+2% +$19.7K 0.05% 249
2016
Q2
$1M Sell
19,931
-461
-2% -$24.5K 0.05% 243
2016
Q1
$1.09M Sell
20,392
-861
-4% -$50.5K 0.06% 230
2015
Q4
$1.4M Sell
21,253
-469
-2% -$29K 0.07% 201
2015
Q3
$1.23M Buy
21,722
+4,783
+28% +$310K 0.07% 214
2015
Q2
$1M Sell
16,939
-4,280
-20% -$264K 0.05% 250
2015
Q1
$1.32M Buy
21,219
+5,549
+35% +$323K 0.07% 224
2014
Q4
$901K Buy
15,670
+255
+2% +$14.2K 0.05% 273
2014
Q3
$828K Sell
15,415
-655
-4% -$34.7K 0.04% 275
2014
Q2
$843K Buy
16,070
+5,412
+51% +$277K 0.04% 279
2014
Q1
$563K Sell
10,658
-1,708
-14% -$78.9K 0.03% 298
2013
Q4
$495K Sell
12,366
-1,277
-9% -$50.3K 0.03% 308
2013
Q3
$515K Sell
13,643
-6,082
-31% -$237K 0.03% 286
2013
Q2
$773K Buy
+19,725
New +$768K 0.05% 209

Other funds holding TEVA

People's United Financial's TEVA Position: Q3 2017 in Review

People's United Financial sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 7,845 shares — an estimated $261K sold.

People's United Financial first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $1.4M in Q4 2015. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • People's United Financial reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • People's United Financial sold 7,845 Teva Pharmaceuticals shares in Q3 2017, an estimated $261K.
  • People's United Financial first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • People's United Financial's Teva Pharmaceuticals position peaked at $1.4M in Q4 2015.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on People's United Financial's 13F filing for Q3 2017, filed 13 Nov 2017.